JP2022527646A5 - - Google Patents
Info
- Publication number
- JP2022527646A5 JP2022527646A5 JP2021560416A JP2021560416A JP2022527646A5 JP 2022527646 A5 JP2022527646 A5 JP 2022527646A5 JP 2021560416 A JP2021560416 A JP 2021560416A JP 2021560416 A JP2021560416 A JP 2021560416A JP 2022527646 A5 JP2022527646 A5 JP 2022527646A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- progression
- disease
- reduce
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025060435A JP2025096316A (ja) | 2019-04-05 | 2025-04-01 | 抗体によって標的化されたファゴサイトーシスにより疾患原因物質を枯渇させる方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830139P | 2019-04-05 | 2019-04-05 | |
| US62/830,139 | 2019-04-05 | ||
| PCT/US2020/026721 WO2020206354A1 (en) | 2019-04-05 | 2020-04-03 | Methods of depleting disease causing agents via antibody targeted phagocytosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060435A Division JP2025096316A (ja) | 2019-04-05 | 2025-04-01 | 抗体によって標的化されたファゴサイトーシスにより疾患原因物質を枯渇させる方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527646A JP2022527646A (ja) | 2022-06-02 |
| JP2022527646A5 true JP2022527646A5 (cg-RX-API-DMAC7.html) | 2023-04-06 |
Family
ID=72667025
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560416A Withdrawn JP2022527646A (ja) | 2019-04-05 | 2020-04-03 | 抗体によって標的化されたファゴサイトーシスにより疾患原因物質を枯渇させる方法 |
| JP2025060435A Pending JP2025096316A (ja) | 2019-04-05 | 2025-04-01 | 抗体によって標的化されたファゴサイトーシスにより疾患原因物質を枯渇させる方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060435A Pending JP2025096316A (ja) | 2019-04-05 | 2025-04-01 | 抗体によって標的化されたファゴサイトーシスにより疾患原因物質を枯渇させる方法 |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019000071A2 (pt) | 2016-07-07 | 2019-07-02 | Bolt Biotherapeutics Inc | conjugados adjuvantes de anticorpo |
| EP3937984A1 (en) | 2019-03-15 | 2022-01-19 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| IL297782A (en) | 2020-05-01 | 2022-12-01 | Bolt Biotherapeutics Inc | Anti-dectin-2 antibodies |
| EP4225373A4 (en) | 2020-10-07 | 2025-01-08 | Dren Bio, Inc. | ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF |
| KR20240170833A (ko) * | 2022-04-04 | 2024-12-04 | 드렌 바이오, 인크. | 덱틴-1 및 cd20에 결합하는 다중특이성 결합 단백질 및 이의 사용 방법 |
| KR20250006353A (ko) * | 2022-04-04 | 2025-01-10 | 드렌 바이오, 인크. | 항-덱틴-1 항체 및 이의 사용 방법 |
| AU2024316588A1 (en) * | 2023-07-31 | 2026-01-29 | Dren Bio Management, Inc. | Multispecific binding proteins that bind dectin-1 and trop-2 and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI423985B (zh) * | 2007-02-23 | 2014-01-21 | 貝勒研究協會 | 利用dectin-1活化人類抗原呈現細胞之醫療應用 |
| US20120244155A1 (en) * | 2011-03-22 | 2012-09-27 | Baylor Research Institute | Dendritic Cells (DCs) Targeting for Tuberculosis (TB) Vaccine |
| WO2018176159A1 (en) * | 2017-03-31 | 2018-10-04 | Zymeworks Inc. | Tumor antigen presentation inducer constructs and uses thereof |
| TW201904588A (zh) * | 2017-06-25 | 2019-02-01 | 美商西雅圖免疫公司 | 引導及導航控制蛋白質之製造及使用方法 |
| CN112567026B (zh) * | 2018-07-19 | 2024-08-23 | 昂科霍斯特公司 | Il-31改善用于癌症的基于巨噬细胞的过继性细胞疗法的功效 |
| SG11202100555PA (en) * | 2018-07-27 | 2021-02-25 | Alector Llc | Anti-siglec-5 antibodies and methods of use thereof |
-
2020
- 2020-04-03 SG SG11202110663UA patent/SG11202110663UA/en unknown
- 2020-04-03 CA CA3136272A patent/CA3136272A1/en active Pending
- 2020-04-03 CN CN202080038435.9A patent/CN114502585A/zh active Pending
- 2020-04-03 JP JP2021560416A patent/JP2022527646A/ja not_active Withdrawn
- 2020-04-03 BR BR112021019950A patent/BR112021019950A2/pt unknown
- 2020-04-03 KR KR1020217036237A patent/KR20220031995A/ko not_active Ceased
- 2020-04-03 US US17/601,359 patent/US20220169737A1/en not_active Abandoned
- 2020-04-03 EP EP20784394.7A patent/EP3947467A4/en active Pending
- 2020-04-03 MX MX2021012035A patent/MX2021012035A/es unknown
- 2020-04-03 WO PCT/US2020/026721 patent/WO2020206354A1/en not_active Ceased
- 2020-04-03 AU AU2020253621A patent/AU2020253621A1/en active Pending
-
2021
- 2021-10-04 IL IL286967A patent/IL286967A/en unknown
-
2024
- 2024-12-10 US US18/975,761 patent/US20250206826A1/en active Pending
-
2025
- 2025-04-01 JP JP2025060435A patent/JP2025096316A/ja active Pending